Enzyme-linked Immunosorbent Assay Market Size & Share, by Type (Indirect ELISA, Sandwich ELISA), End User (Hospitals, Pharmaceutical, Research and Academic Institutions) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5526
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Enzyme-linked Immunosorbent Assay Landscape

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • BD (Becton, Dickinson and Company)
    • Agilent Technologies, Inc.
    • BioMérieux SA
    • Ortho Clinical Diagnostics

Browse Key Market Insights with Data Illustration:


In The News

  • In July 2023, PerkinElmer acquired Serena Therapeutics, a leader in liquid biopsy technologies for early cancer detection, for USD 2.1 billion. This acquisition significantly expands PerkinElmer's diagnostics portfolio and positions them as a major player in the growing liquid biopsy market.
  • In October 2023, PerkinElmer introduced the EnVista™ 10X microscope, a groundbreaking platform combining high-resolution optical microscopy with powerful correlative analysis capabilities. This innovative tool allows researchers to gain deeper insights into complex biological processes across various disciplines.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5526
  • Published Date: Jan 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of enzyme-linked immunosorbent assay is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market Thermo Fisher Scientific Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Merck KGaA (EMD Millipore), F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying